These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 767106)

  • 1. The linkage of lysine in the O-specific chains of Proteus mirabilis 1959.
    Gromska W; Mayer H
    Eur J Biochem; 1976 Feb; 62(2):391-9. PubMed ID: 767106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ribitol-phosphate-containing lipopolysaccharide from Proteus mirabilis, strain D52. Investigations on the structure of O-specific chains.
    Gmeiner J
    Eur J Biochem; 1977 Mar; 74(1):171-80. PubMed ID: 323005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and epitope characterisation of the O-specific polysaccharide of Proteus mirabilis O28 containing amides of D-galacturonic acid with L-serine and L-lysine.
    Radziejewska-Lebrecht J; Shashkov AS; Vinogradov EV; Grosskurth H; Bartodziejska B; Rozalski A; Kaca W; Kononov LO; Chernyak AY; Mayer H
    Eur J Biochem; 1995 Jun; 230(2):705-12. PubMed ID: 7541753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical studies on the O-specific side chains of the heterogeneous lipopolysaccharide from Proteus mirabilis O27.
    Gromska W; Krajewska D
    Arch Immunol Ther Exp (Warsz); 1981; 29(5):595-600. PubMed ID: 6181757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of Proteus mirabilis O27 O-specific polysaccharide containing amino acids and phosphoethanolamine.
    Vinogradov EV; Krajewska-Pietrasik D; Kaca W; Shashkov AS; Knirel YA; Kochetkov NK
    Eur J Biochem; 1989 Nov; 185(3):645-50. PubMed ID: 2686990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and serological characterization of an Nepsilon-[(R)-1-carboxyethyl]-L-lysine-containing O-chain of the lipopolysaccharide of Proteus mirabilis O13.
    Swierzko AS; Cedzyński M; Ziółkowski A; Senchenkova SN; Perepelov AV; Knirel YA; Kaca W
    Arch Immunol Ther Exp (Warsz); 2001; 49(2):163-9. PubMed ID: 11348021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotyping of Proteus mirabilis clinical strains based on lipopolysaccharide O-polysaccharide and core oligosaccharide structures.
    Kaca W; Glenska J; Lechowicz L; Grabowski S; Brauner A; Kwinkowski M
    Biochemistry (Mosc); 2011 Jul; 76(7):851-61. PubMed ID: 21999547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core region in Proteus mirabilis lipopolysaccharide.
    Kotełko K; Gromska W; Papierz M; Sidorczyk Z; Krajewska D; Szer K
    J Hyg Epidemiol Microbiol Immunol; 1977; 21(3):271-84. PubMed ID: 342599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galacturonic acid as the terminal constituent in the R core polysaccharide of proteus R110 (Ra) mutant.
    Kotełko K; Deka M; Gromska W; Kaca W; Radziejewska-Lebrecht J; Rozalski A
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):833-8. PubMed ID: 6378134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical characterization of lipopolysaccharides from Proteus strains used in Weil-Felix test.
    Mizushiri S; Amano K; Fuji S; Fukushi K; Watanabe M
    Microbiol Immunol; 1990; 34(2):121-33. PubMed ID: 2189059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and immunochemical studies on the lipopolysaccharide of the 'T-antigen'-containing mutant Proteus mirabilis R14/1959.
    Bartodziejska B; Radziejewska-Lebrecht J; Lipinska M; Knirel YA; Kononov LO; Chernyak AY; Mayer H; Rozalski A
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):113-21. PubMed ID: 8731019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structure of a new lysine-containing O-specific polysaccharide from Proteus mirabilis O26].
    Shashkov AS; Toukach FV; Paramonov NA; Senchenkova SN; Katsa V; Knirel' IuA
    Biokhimiia; 1996 Jan; 61(1):24-33. PubMed ID: 8679775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural studies on the glucose-heptose region of the Proteus mirabilis R core.
    Radziejewska-Lebrecht J; Feige U; Jensen M; Kotełko K; Friebolin H; Mayer H
    Eur J Biochem; 1980; 107(1):31-8. PubMed ID: 6995114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of lysine in the serological specificity of some Proteus mirabilis lipopolysaccharides.
    Gromska W; Kaca W; Kotełko K
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):237. PubMed ID: 86335
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical characterization and serological properties of a unique O-polysaccharide of the Proteus mirabilis Sm 99 clinical strain - Identification of a new, O81, serotype.
    Zabłotni A; Arbatsky NP; Drzewiecka D; Shashkov AS; Knirel YA
    Int J Biol Macromol; 2018 Oct; 118(Pt A):1131-1135. PubMed ID: 30001599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of 2-amino-2-deoxy-hexuronic acids as constituents of Vibrio parahaemolyticus K15 antigen.
    Torii M; Sakakibara K; Kuroda K
    Eur J Biochem; 1973 Sep; 37(3):401-5. PubMed ID: 4204717
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipopolysaccharide phage receptor of Proteus mirabilis 1959 strain. Site of phage-mediated hydrolysis in O-specific polysaccharide.
    Kaca W; Kotełko K
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):905-14. PubMed ID: 6378136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The amide of galacturonic acid with lysine as an immunodominant component of the lipopolysaccharide core region from Proteus penneri 42 strain.
    Palusiak A; Maciejewska A; Ługowski C; Różalski A
    Acta Biochim Pol; 2014; 61(1):129-32. PubMed ID: 24644555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on lipopolysaccharides of Proteus mirabilis serotypes.
    Sidorczyk Z; Kotelko K
    Arch Immunol Ther Exp (Warsz); 1973; 21(6):829-38. PubMed ID: 4784636
    [No Abstract]   [Full Text] [Related]  

  • 20. The structure and serological specificity of Proteus mirabilis O43 O antigen.
    Cedzyński M; Knirel YA; Rózalski A; Shashkov AS; Vinogradov EV; Kaca W
    Eur J Biochem; 1995 Sep; 232(2):558-62. PubMed ID: 7556207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.